WHY ISRAEL?
sector activity in fuelling the economy. Start-Up Nation looks at this statistic over a six-year period, including the post Internet fizzle. Israel’s civilian R&D expenditure for this period was 4.5 percent of its GDP. By comparison, in this period, the US showed an investment of 2.7 percent of its GDP, while Germany and the UK showed an investment of 2.5 percent and 1.9 percent respectively; Japan’s civilian R&D expenditure of 3.2 percent is nearly 20 percent more than that of the US, but Israel’s is 40 percent higher than Japan’s and 67 percent higher than that of the US.
Non-US companies on NASDAQ (2009)
In 2010, excluding the US itself and the 72 companies headquartered for tax purposes in the Cayman Islands, Bermuda and the British Virgin Islands, Israel, with 60 companies, had the largest number of companies traded on NASDAQ of any foreign country. While that may not sound terribly impressive, in comparison, Japan had only four. Te rest of the list includes the following: Ireland (7), UK (5), Singapore (4), India (3), Korea (1), France (2), Germany (1), China and Hong Kong (3). Even Canada, which may have been expected to have a large presence on NASDAQ, and which does indeed have a presence that far exceeds that of the above list of countries, had only 45.
Patent activity
centre in Israel in the 1970s and is now active in four different Israeli cities. In addition to R&D, much of the company’s chip manufacturing takes place in Israel. Warren Buffett bought the Israeli company Isscar, which makes hard-metal cutting tools, for a multi-billion dollar sum during the second Lebanon war in 2006, despite the Galilean company being in the war zone.
Each book has its own reasoning as to why Israel has achieved this leadership role in just a few years, despite many disadvantages. However, as stated by James Glassman, in his Wall Street Journal review of Start-Up Nation: “In the end, it is not easy to discover why Israel, a tiny nation of immigrants torn by war, has managed to become the first technology nation. It may be enough, as this fine book does, to shine a spotlight on its success.”
www.worldipreview.com
Per capita venture capital investment
As shown in Start-Up Nation venture capital investment (VCI) per capita in Israel in 2007 was $225. Tis is more than twice the VCI per capita of $100 for the US, which came second, ahead of Ireland, Denmark, the UK, the UAE, France, Singapore, China, Korea and India.
With the exception of the UAE, the only country to show growth in venture capital investment from 2007 to 2008 was Israel, with a VCI of more than $250 per capita.
Civilian R&D expenditure (2000- 2005) as percentage of GDP
Civilian R&D expenditure as a percentage of gross domestic product (GDP) is an indication of private
In developed economies, the ability to stake out intellectual property rights in general, and patent rights in particular, is a necessary part of doing business. It is a good indicator of economic activity.
Israel patent filings
In the WIPO report entitled World Intellectual Property Indicators 2009, it is shown that 8,009 patent applications were filed in Israel during 2007. Of these, 1,615 were ‘resident’ filings by Israeli companies or individuals; and 6,394 originated from outside Israel.
In 2007, the PCT Israel receiving office handled a total of 1,882 international applications. Tis is a good indicator of the number of domestically originating inventions with opportunities overseas. (Te difference between the 1,882 Israeli-originating international applications and the 1,615 resident filings can be explained mainly by the fact that Israeli companies sometimes make their initial filings overseas, typically in the US, and may not file in Israel
World Intellectual Property Review May/June 2011 33
©
iStockphoto.com / slidezero_com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84